MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine.

Aarnoudse, AL; van Schaik, RH; Dieleman, J; Molokhia, M; van Riemsdijk, MM; Ligthelm, RJ; Overbosch, D; van der Heiden, IP; Stricker, BH; (2006) MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine. Clinical pharmacology and therapeutics, 80 (4). pp. 367-374. ISSN 0009-9236 DOI: https://doi.org/10.1016/j.clpt.2006.07.003

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.clpt.2006.07.003

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar